Cuban anti-cancer vaccines soon to be available in Serbia
Certain quantities of CimaVax-EGF, a Cuban-developed drug used for lung cancer therapy, will soon be available in Serbia.
A memorandum on the procurement of 1,680 units of the CimaVax-EGF vaccine has been signed between the Cuban CIMAB and the Serbian Institute of Virology, Vaccines and Sera Torlak, the Ministry of Health said on its official website.
- Log in to post comments